Amyloid precursor protein mRNA levels in Alzheimer's disease brain

Molecular Brain Research

Volumn 122, Issue 1, 2004, Pages 1-9

  Preece, Paul ^a   Virley, David J ^b   Costandi, Moheb ^c   Coombes, Robert ^d   Moss, Stephen J ^d   Mudge, Anne W ^d   Jazin, Elena ^e   Cairns, Nigel J ^f  

^a Seixo Branco   (Spain)

^b GLAXOSMITHKLINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UPPSALA UNIVERSITY   (Sweden)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Degenerative disease: Alzheimer's miscellaneous; Disorders of the nervous system; Human brain; MRNA; Quantification; TaqMan

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; ISOPROTEIN; MESSENGER RNA; SERINE PROTEINASE INHIBITOR;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DEATH; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PH MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA PROBE;

EID: 1342306724     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.08.022     Document Type: Article

References (50)

1. Abe K., Tanzi R.E., Kogure K. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125:1991;172-174.
2. Altschul S., Gish W., Miller W., Myers E., Lipman D. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Bond B.C., Virley D.J., Cairns N.J., Moore G., Moss S.J., Mudge A.W., Walsh F.W., Jazin E., Preece P. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Mol. Brain Res. 106:2002;101-116.
4. Castensson A., Emilsson L., Preece P., Jazin E. High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res. 10:2000;1219-1229.
5. Clark A.W., Parhad I.M. Expression of neuronal mRNAs in Alzheimer type degeneration of the nervous system. Can. J. Neurol. Sci. 16:1989;477-482.
6. Clark A.W., Krekoski C.A., Parhad I.M., Liston D., Julien J.P., Hoar D.I. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann. Neurol. 25:1989;331-339.
7. Cochran W.G., Cox G.M. Experimental Designs. 2nd ed. 1957;Wiley, New York.
8. de Sauvage F., Octave J.N. A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science. 245:1989;651-653.
9. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001.
10. Golde T.E., Estus S., Usiak M., Younkin L.H., Younkin S.G. Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron. 4:1990;253-267.
11. Griffin W.S.T., Stanley L.C. Glial activation as a common denominator in neurodegenerative disease: a hypothesis in neuropathophysiology. Biology and Pathology of Astrocyte-Neuron Interactions. 1993;359-381 Plenum, New York.
12. Harrison P.J., Barton A.J., Procter A.W., Bowen D.M., Pearson R.C. The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortex. J. Neurochem. 62:1994;635-644.
13. Harrison P.J., Wighton-Benn W.H., Heffernan J.M., Sanders M.W., Pearson R.C. Amyloid precursor protein mRNAs in Alzheimer's disease. Neurodegeneration. 5:1996;409-415.
14. Hattori M., Tsukahara F., Furuhata Y., Tanahashi H., Hirose M., Saito M., Tsukuni S., Sakaki Y. A novel method for making nested deletions and its application for sequencing of a 300 kb region of human APP locus. Nucleic Acids Res. 25:1997;1802-1808.
15. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
16. Hulette C., Mirra S., Wilkinson W., Heyman A., Fillenbaum G., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 45:1995;1991-1995.
17. Jacobsen J.S., Blume A.J., Vitek M.P. Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis. Neurobiol. Aging. 12:1991;585-592.
18. Jacobsen J.S., Muenkel H.A., Blume A.J., Vitek M.P. A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs. Neurobiol. Aging. 12:1991;575-583.
19. Johnson S.A., Pasinetti G.M., May P.C., Ponte P.A., Cordell B., Finch C.E. Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp. Neurol. 102:1988;264-268.
20. Johnson S.A., Rogers J., Finch C.E. APP-695 transcript prevalence is selectively reduced during Alzheimer's disease in cortex and hippocampus but not in cerebellum. Neurobiol. Aging. 10:1989;755-760.
21. Johnson S.A., McNeill T., Cordell B., Finch C.E. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science. 248:1990;854-857.
22. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., Lust W.D. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. NeuroReport. 4:1993;211-214.
23. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
24. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 331:1988;530-532.
25. Kitaguchi N., Tokushima Y., Oishi K., Takahashi Y., Shiojiri S., Nakamura S., Tanaka S., Kodaira R., Ito H. Determination of amyloid beta protein precursors harboring active form of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-antibody sandwich ELISA. Biochem. Biophys. Res. Commun. 166:1990;1453-1459.
26. Konig G., Salbaum J.M., Wiestler O., Lang W., Schmitt H.P., Masters C.L., Beyreuther K. Alternative splicing of the beta A4 amyloid gene of Alzheimer's disease in cortex of control and Alzheimer's disease patients. Brain Res. Mol. Brain Res. 9:1991;259-262.
27. Koo E.H., Sisodia S.S., Cork L.C., Unterbeck A., Bayney R.M., Price D.L. Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer's disease and in aged nonhuman primates. Neuron. 4:1990;97-104.
28. Kunitz M. J. Gen. Physiol. 10:1947.
29. Lie Y.S., Petropoulos C.J. Advances in quantitative PCR technology: 5′ nuclease assays. Curr. Opin. Biotechnol. 9:1998;43-48.
30. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
31. Moir R.D., Lynch T., Bush A.I., Whyte S., Henry A., Portbury S., Multhaup G., Small D.H., Tanzi R.E., Beyreuther K., Masters C.L. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. J. Biol. Chem. 273:1998;5013-5019.
32. Neve R.L., Finch E.A., Dawes L.R. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron. 1:1988;669-677.
33. Neve R.L., Rogers J., Higgins G.A. The Alzheimer amyloid precursor-related transcript lacking the beta/A4 sequence is specifically increased in Alzheimer's disease brain. Neuron. 5:1990;329-338.
34. Ohyagi Y., Takahashi K., Satoh Y., Makifuchi T., Tabira T. Cerebral cortical amyloid protein precursor mRNA expression is similar in Alzheimer's disease and other neurodegenerative diseases. J. Neurol. Sci. 111:1992;33-38.
35. Okada A., Urakami K., Takahashi K., Ohno K., Sato K., Endo H. Expression of amyloid beta-protein precursor mRNAs in cultured skin fibroblasts taken from patients with dementia of the Alzheimer type [letter]. Dementia. 5:1994;55-56.
36. Oltersdorf T., Fritz L.C., Schenk D.B., Lieberburg I., Johnson-Wood K.L., Beattie E.C., Ward P.J., Blacher R.W., Dovey H.F., Sinha S. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature. 341:1989;144-147.
37. Oyama F., Shimada H., Oyama R., Titani K., Ihara Y. Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau. J. Neuropathol. Exp. Neurol. 50:1991;560-578.
38. Palmert M.R., Golde T.E., Cohen M.L., Kovacs D.M., Tanzi R.E., Gusella J.F., Usiak M.F., Younkin L.H., Younkin S.G. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science. 241:1988;1080-1084.
39. Palmert M.R., Usiak M., Mayeux R., Raskind M., Tourtellotte W.W., Younkin S.G. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology. 40:1990;1028-1034.
40. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 331:1988;525-527.
41. Preece P., Cairns N.J. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Mol. Brain Res. 118:2003;60-71.
42. Preece P., Virley D.J., Costandi M., Coombes R., Moss S.J., Mudge A.W., Jazin E., Cairns N.J. An optimistic view for quantifying mRNA in post-mortem human brain. Mol. Brain Res. 116:2003;7-16.
43. Rockenstein E.M., McConlogue L., Tan H., Power M., Masliah E., Mucke L. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270:1995;28257-28267.
44. Siman R., Card J.P., Nelson R.B., Davis L.G. Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron. 3:1989;275-285.
45. Sola C., Garcia-Ladona F.J., Mengod G., Probst A., Frey P., Palacios J.M. Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage. Brain Res. Mol. Brain Res. 17:1993;41-52.
46. Sola C., Mengod G., Probst A., Palacios J.M. Differential regional and cellular distribution of beta-amyloid precursor protein messenger RNAs containing and lacking the Kunitz protease inhibitor domain in the brain of human, rat and mouse. Neuroscience. 53:1993;267-295.
47. Tanaka S., Nakamura S., Ueda K., Kameyama M., Shiojiri S., Takahashi Y., Kitaguchi N., Ito H. Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease. Biochem. Biophys. Res. Commun. 157:1988;472-479.
48. Tanaka S., Liu L., Kimura J., Shiojiri S., Takahashi Y., Kitaguchi N., Nakamura S., Ueda K. Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders. Brain Res. Mol. Brain Res. 15:1992;303-310.
49. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 331:1988;528-530.
50. Willoughby D.A., Johnson S.A., Pasinetti G.M., Tocco G., Najm I., Baudry M., Finch C.E. Amyloid precursor protein mRNA encoding the Kunitz protease inhibitor domain is increased by kainic acid-induced seizures in rat hippocampus. Exp. Neurol. 118:1992;332-339.